Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treosulfan Based Conditioning”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Study completedNCT01062490
What this trial is testing

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
medac GmbH 45
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Early research (Phase 1)Ended earlyNCT03963024
What this trial is testing

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

Who this might be right for
Irradiated Bone MarrowTransplant-Related Hematologic MalignancyLeukemia, Acute+2 more
IRCCS San Raffaele 9
Large-scale testing (Phase 3)Study completedNCT00822393
What this trial is testing

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
medac GmbH 570
Testing effectiveness (Phase 2)Looking for participantsNCT06198842
What this trial is testing

Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome

Who this might be right for
Nijmegen Breakage Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07214064
What this trial is testing

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

Who this might be right for
AML (Acute Myeloid Leukemia)MDS/AMLMDS (Myelodysplastic Syndrome)
University Hospital Tuebingen 27
Testing effectiveness (Phase 2)Study completedNCT01063660
What this trial is testing

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
medac GmbH 75
Testing effectiveness (Phase 2)Ended earlyNCT04994808
What this trial is testing

Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Fred Hutchinson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT04965597
What this trial is testing

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Who this might be right for
Bone Marrow Failure SyndromeCongenital Amegakaryocytic ThrombocytopeniaDiamond-Blackfan Anemia+6 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07316595
What this trial is testing

Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

Who this might be right for
HSCTNijmegen Breakage SyndromeTreosulfan Based Conditioning
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 24
Testing effectiveness (Phase 2)UnknownNCT01079013
What this trial is testing

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaHodgkin Lymphoma
Sheba Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00491634
What this trial is testing

Treosulfan-based Conditioning for Transplantation in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Dr. Avichai Shimoni MD 24
Testing effectiveness (Phase 2)UnknownNCT04400045
What this trial is testing

Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

Who this might be right for
Nijmegen Breakage Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 10
Testing effectiveness (Phase 2)Study completedNCT02333058
What this trial is testing

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukaemias (ALL)Acute Myeloid Leukaemias (AML)Myelodysplastic Syndromes (MDS)+1 more
medac GmbH 70
Testing effectiveness (Phase 2)Study completedNCT02349906
What this trial is testing

Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

Who this might be right for
Primary ImmunodeficienciesInborn Errors of MetabolismHaemoglobinopathies+1 more
medac GmbH 106
Testing effectiveness (Phase 2)UnknownNCT00598624
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome+4 more
IRCCS San Raffaele 175